Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites

Nature Cell Biology

Volumn 12, Issue 8, 2010, Pages 768-780

  Martinez, Paula ^a   Thanasoula, Maria ^a   Carlos, Ana R ^b   Gómez López, Gonzalo ^a   Tejera, Agueda M ^a   Schoeftner, Stefan ^a   Dominguez, Orlando ^a   Pisano, David G ^a   Tarsounas, Madalena ^b   Blasco, Maria A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RAP1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMOSOME FRAGILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HYPERPIGMENTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; TELOMERE; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; BODY WEIGHT; CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERE; TELOMERE-BINDING PROTEINS;

MAMMALIA; MUS;

EID: 77955173402     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb2081     Document Type: Article

References (48)

1. de Lange, T. Shelterin: the protein complex that shapes and safeguards human telom-eres. Genes Dev. 19, 2100-2110 (2005).
2. Shore, D. & Nasmyth, K. Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elements. Cell 51, 721-732 (1987).
3. Li, B., Oestreich, S. & de Lange, T. Identification of human Rap1: implications for telomere evolution. Cell 101, 471-483 (2000).
4. Kyrion, G., Liu, K., Liu, C. & Lustig, A. J. Rap1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev. 7, 1146-1159 (1993).
5. Marcand, S., Gilson, E. & Shore, D. A protein-counting mechanism for telomere length regulation in yeast. Science 275, 986-990 (1997).
6. Hecht, A., Laroche, T., Strahl-Bolsinger, S., Gasser, S. M. & Grunstein, M. Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a molecular model for the formation of heterochromatin in yeast. Cell 80, 583-592 (1995).
7. Tanny, J. C., Dowd, G. J., Huang, J., Hilz, H. & Moazed, D. An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell 99, 735-745 (1999).
8. Carmen, A. A., Milne, L. & Grunstein, M. Acetylation of the yeast histone H4 N terminus regulates its binding to heterochromatin protein SIR3. J. Biol. Chem. 277, 4778-4781 (2002).
9. Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800 (2000).
10. Conrad, M. N., Wright, J. H., Wolf, A. J. & Zakian, V. A. Rap1 protein interacts with yeast telomeres in vivo: overproduction alters telomere structure and decreases chromosome stability. Cell 63, 739-750 (1990).
11. Buchman, A. R., Kimmerly, W. J., Rine, J. & Kornberg, R. D. Two DNA-binding factors recognize specific sequences at silencers, upstream activating sequences, autonomously replicating sequences, and telomeres in Saccharomyces cerevisiae. Mol. Cell. Biol. 8, 210-225 (1988).
12. +-ATPase gene is controlled by the promoter binding factor TUF. J. Biol. Chem. 264, 7437-7446 (1989).
13. Sfeir, A., Kabir, S., van Overbeek, M., Celli, G. B. & de Lange, T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 327, 1657-1661 (2010).
14. Martinez, P. et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 23, 2060-2075 (2009).
15. Tejera, A. et al. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev. Cell 18, 775-789 (2010).
16. Yang, X., Figueiredo, L. M., Espinal, A., Okubo, E. & Li, B. Rap1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei. Cell 137, 99-109 (2009).
17. Rodriguez, C. I. et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25, 139-140 (2000).
18. Tan, M., Wei, C. & Price, C. M. The telomeric protein Rap1 is conserved in vertebrates and is expressed from a bidirectional promoter positioned between the Rap1 and KARS genes. Gene 323, 1-10 (2003).
19. d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198 (2003).
20. Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telom-eres. Curr. Biol. 13, 1549-1556 (2003).
21. Silver, D. P. & Livingston, D. M. Self-excising retroviral vectors encoding the Cre recom-binase overcome Cre-mediated cellular toxicity. Mol. Cell 8, 233-243 (2001).
22. Blanco, R., Munoz, P., Flores, J. M., Klatt, P. & Blasco, M. A. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 21, 206-220 (2007).
23. Munoz, P., Blanco, R., Flores, J. M. & Blasco, M. A. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat. Genet. 37, 1063-1071 (2005).
24. Sfeir, A. et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90-103 (2009).
25. Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66-72 (2009).
26. Tarutani, M. et al. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc. Natl Acad. Sci. USA 94, 7400-7405 (1997).
27. Ramirez, A., Bravo, A., Jorcano, J. L. & Vidal, M. Sequences 5 of the bovine keratin 5 gene direct tissue-and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58, 53-64 (1994).
28. Benetti, R., Garcia-Cao, M. & Blasco, M. A. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 39, 243-250 (2007).
29. Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E. & Lingner, J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318, 798-801 (2007).
30. Schoeftner, S. & Blasco, M. A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 10, 228-236 (2008).
31. Estep, P. W. 3rd, Warner, J. B. & Bulyk, M. L. Short-term calorie restriction in male mice feminizes gene expression and alters key regulators of conserved aging regulatory pathways. PLoS ONE 4, e5242 (2009).
32. Crowley, V. E., Yeo, G. S. & O'Rahilly, S. Obesity therapy: altering the energy intake-and-expenditure balance sheet. Nat. Rev. Drug Discov. 1, 276-286 (2002).
33. Leone, T. C. et al. PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3, e101 (2005).
34. Pavesi, G., Mereghetti, P., Mauri, G. & Pesole, G. Weeder web: discovery of transcription factor binding sites in a set of sequences from co-regulated genes. Nucleic Acids Res. 32, W199-W200 (2004).
35. Bae, N. S. & Baumann, P. A Rap1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 26, 323-334 (2007).
36. Sarthy, J., Bae, N. S., Scrafford, J. & Baumann, P. Human Rap1 inhibits non-homologous end joining at telomeres. EMBO J. 28, 3390-3399 (2009).
37. Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317-1326 (2007).
38. Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555 (1999).
39. Tsakiri, K. D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA 104, 7552-7557 (2007).
40. Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432-435 (2001). (Pubitemid 32928599)
41. Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413-1424 (2005).
42. Moretti, P., Freeman, K., Coodly, L. & Shore, D. Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein Rap1. Genes Dev. 8, 2257-2269 (1994).
43. Schoeftner, S. et al. Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations. Proc. Natl Acad. Sci. USA 106, 19393-19398 (2009).
44. Bradshaw, P. S., Stavropoulos, D. J. & Meyn, M. S. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat. Genet. 37, 193-197 (2005).
45. Deng, Z., Atanasiu, C., Burg, J. S., Broccoli, D. & Lieberman, P. M. Telomere repeat binding factors TRF1, TRF2, and hRap1 modulate replication of Epstein-Barr virus OriP. J. Virol. 77, 11992-12001 (2003).
46. Mignon-Ravix, C., Depetris, D., Delobel, B., Croquette, M. F. & Mattei, M. G. A human interstitial telomere associates in vivo with specific TRF2 and TIN2 proteins. Eur J. Hum. Genet. 10, 107-112 (2002).
47. Smogorzewska, A. et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20, 1659-1668 (2000).
48. Zhang, P. et al. Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells. Curr. Biol. 18, 1489-1494 (2008).